Jacob Gottlieb, the founder and former CIO of the now defunct Visium Asset Management, is today the head of Altium Capital. Visium fell via a scandal that did not involve Gottlieb. Gottlieb first entered adult life by earning his B.A. in Economics from Brown University and then his M.D. from NYU Medical School. It was during his medical internship at St. Vincent’s Hospital that he decided that a career in finances was the way for him to go so after his internship we worked toward and in 2001 was awarded the Certified Financial Analyst designation.
After this designation, he filled several financial positions over the next few years. His career really took off during his time with Balyasny Asset Management. In 2005, he left Balyasny to co-found Visium with several friends and family members. Gottlieb played an instrumental role in helping the group raise $300 million in seed money. Visium would go on to be so successful that at its peak it would manage around $8 billion, 170 employees, and offices in New York, London, and San Francisco. This growing success ended after three of its employees were charged and convicted of securities mismarking and insider trading.
Visium might have continued, but the scandal cause so much panic and chaos among investors and employees alike that Gottlieb made the hard decision to shut down operations completely. But Gottlieb was not to stay down for long. Altium is showing just as much promise as Visium. At the present time Visum shares New York City office space with Oramed Pharmaceuticals Inc. and Sellas Life Sciences. All three companies are recognized as having very probable huge impacts on future culture. Gottlieb is also an active investor in both Oramed and Sellas. He is very optimistic about the futures of all three of his investments.